Jung Hun Kang

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

Jung Hun Kang, Soon Il Lee, Do Hyoung Lim et al. · Journal of Clinical Oncology · 2012 · 672 citations

Medicine, Oncology, Chemotherapy +5

Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study

Se Hoon Park, Heung-Moon Chang, Jun Suk Kim et al. · The Lancet Oncology · 2011 · 483 citations

Medicine, Oncology, Pharmacology +9

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study

David Hui, Omar Shamieh, Carlos Eduardo Paiva et al. · Cancer · 2015 · 247 citations · Full text

Nursing, Oncology, Cancer Symptom Management +16

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

James J. Harding, Jia Fan, Do‐Youn Oh et al. · The Lancet Oncology · 2023 · 247 citations · Full text

Medicine, Oncology, Pharmacology +10